Biomarkers in early-stage colorectal cancer: ready for prime time?
BACKGROUND/AIMS: During the last two decades, hundreds of reports have detailed putative prognostic and predictive biomarkers for colorectal cancer (CRC). However, the majority of these studies have been small and retrospective, reporting results that are highly likely to represent false positives....
Những tác giả chính: | Church, D, Midgley, R, Kerr, D |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2012
|
Những quyển sách tương tự
-
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
Bằng: Midgley, R, et al.
Được phát hành: (2005) -
The emergence of 'omics for the management of colorectal cancer.
Bằng: Midgley, R, et al.
Được phát hành: (2011) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
Bằng: Midgley, R, et al.
Được phát hành: (2005) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
Bằng: Joao Paulo Solar Vasconcelos, et al.
Được phát hành: (2022-12-01) -
Immunotherapy for colorectal cancer.
Bằng: Midgley, R, et al.
Được phát hành: (2003)